Rasagiline CAS NO.136236-51-6

Superior quality, moderate price & quick delivery.

Hangzhou Yunuo Chemical Co., Ltd. is located in Hangzhou City, China. We are specialized in fine chemicals and medical intermediate, Organic compounds, rubber chemicals etc. We have the advanced technology strength, owning delicate instruments and strong development team.

Our value:                                         
1. Customer Satisfaction is our priority and guarantee for the future,we are your faithful partner.
2. We co-develop products and projects with our partners.
3. We are passionate about the success of our projects, bound in an alliance of mutual benefit.

Rasagiline (Azilect, TVP-1012, N-propargyl-1(R)-aminoindan) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases.

The racemic form of the drug was invented by Aspro Nicholas in the early 1979s. Moussa B.H. Youdimidentified it as a potential drug for Parkinson's disease, and working with collaborators at Technion – Israel Institute of Technology in Israel and the drug company, Teva Pharmaceutical, identified the R-isomer as the active form of the drug. Teva brought it to market in partnership with Lundbeck in Europe and Eisai in the US and elsewhere. It was approved in Europe in 2005 and in the US in 2006.